Sarah Karlin-Smith Retweeted Aaron Kesselheim
This is important point that gets lost in the rtt debate. Lots of people who are opposed do want to find ways to get more patients access to experimental meds when appropriate. They just don’t think this bill will do that.https://twitter.com/akesselheim/status/973729770356793344 …
Sarah Karlin-Smith added,
Aaron Kesselheim @akesselheim
Now that this is hopefully out of the way for good, we can think more rationally about improving the current expended access pathway and trying to ensure that patients seeking investigational drugs can get into rigorous clinical trials of them https://twitter.com/statnews/status/973696033527037952 …
5:43 AM - 14 Mar 2018
0 replies
3 retweets
16 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.